We’re open everyday 24/7
Get help now
Free & confidential
Almost 7 million people in the United States, or nearly 3 percent of the population, are affected by panic disorder. Women are more likely than men to have panic disorder, according to the Anxiety and Depression Association of America. Panic attacks can occur at any time of the day or night, and they may cause some people to avoid daily activities, such as going to work or school. Some people who are affected by panic attacks do not tell their doctor out of fear as being labeled a hypochondriac.
However, panic disorder is very treatable, and those who use Effexor to treat it experience a much-reduced rate of relapse. Keep reading to learn about how Effexor works with panic disorders.
Effexor is the brand name of venlafaxine, which is no longer sold in the United States, per Everyday Health. Effexor XR, the extended-release form of Effexor, is a selective serotonin and norepinephrine reuptake inhibitor (SNRIs) antidepressant, and it is sold in the U.S. The prescription drug affects chemicals in the brain that could be unbalanced in people with depression. An SNRI works by increasing the brain’s levels of serotonin and norepinephrine. These are neurotransmitters that act together to brighten mood and relieve anxiety.
A study found that Effexor XR was more effective than a placebo in both long- and short-term treatments of panic disorder. It also resulted in significantly reduced relapse rates. The drug may start working within the first two weeks by improving energy, sleep, and appetite. If these changes are noticed, it is a good sign that the drug is working. Still, it may take longer for the symptoms of depression or panic disorder to be eased.
Panic disorder happens when a person experiences unexpected and repeated episodes of intense fear. Physical symptoms of these episodes may include sweating, heart palpitations, shortness of breath, dizziness, or nausea. It is also common to fear that future episodes may occur.
The American Academy of Family Physicians states that panic disorder is diagnosed when a patient experiences recurring, unexpected panic attacks and relays at least one of the following characteristics:
The signs or symptoms of a panic disorder, as noted by the Mayo Clinic, may include:
Effexor XR is an SSRI and a norepinephrine medication. Both of the neurotransmitters, serotonin, and norepinephrine, are considered to be linked to panic disorder, as both play an essential role in the regulation of specific functions and emotions that affect panic disorder.
Serotonin is thought to be connected to mood and sleep. Norepinephrine is thought to be responsible for how someone reacts to stress and anxiety. Since the drug contains medication that regulates these functions, it helps to alleviate panic attacks by reducing the feelings of anxiety and improves a person’s mood.
Ready to get Help?
Talk to a treatment expert
If you or someone you know is experiencing recurring panic attacks, they may have panic disorder. A doctor can diagnose it and prescribe Effexor if it is the right medication to use.
Anxiety and Depression Association of America. Facts. Retrieved from https://adaa.org/about-adaa/press-room/facts-statistics
Everyday Health. (2014, November 5) Venlafaxine. Halperin, K. Retrieved from https://www.everydayhealth.com/drugs/effexor#basics
Therapeutics and Clinical Risk Management. (2007, March 3) Kjernisted, K., McIntosh, D. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936289/
American Academy of Family Physicians. University of Illinois College of Medicine at Peoria. (1998, May 15) Saeed, S.A., M.D., Bruce, T. Retrieved from https://www.aafp.org/afp/1998/0515/p2405.html
Mayo Clinic. (2018, May 4) Panic attacks and panic disorder. Retrieved from https://www.mayoclinic.org/diseases-conditions/panic-attacks/symptoms-causes/syc-20376021
verywellmind. (2020, March 23) Taking SNRIs for Treating Panic Disorder. How They Work in Treating Anxiety and Panic Disorders. Star, K., Ph.D. Retrieved from https://www.verywellmind.com/serotonin-and-norepinephrine-reuptake-inhibitors-snris-2584366